EDECRIN
Pronunciation: eth-a-KRIN-ik AS-id


What it isNKCC2-inhibiting loop diuretic; edema when a non-sulfonamide option is required.
Why this oneIts lack of a sulfonamide group is its defining niche among loop diuretics.
What limits itOtotoxicity is greater than with other loops; electrolyte depletion and high cost otherwise mirror the class.
Animated chart of estimated U.S. prescriptions per year, Diuretics (1953–2026). Ethacrynic acid enters in 1967 (estimated).
Principal riskThe highest ototoxicity of the loop diuretics
No sulfonamide
The loop diuretic with no sulfonamide group — the traditional alternative after a sulfonamide reaction, though the sulfonamide loops rarely need replacing.
Open the sulfonamide hypersensitivity presentation → · sources [n] are on its References slide.
Legacy pregnancy categoryC
Defining liabilityVolume depletion and electrolyte disturbances; kidney function and interacting medications modify risk.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Edema / diuresis | adult | 50 mg QD after a meal | 50-200 mg daily | 200 mg BID |
| Edema / diuresis | pediatric (excl. infants) | 25 mg QD | individualized |
Titration Adjust in 25-50 mg increments; escalate over successive days
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy No adequate studies; animal studies showed no teratogenicity; use only if clearly needed.
Lactation Undefined
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 25 mg | tab | 30 qd | $24.20 | offered |
Generic entry2016
Open Ethacrynic acid in the interactive console ↗

Open Ethacrynic acid in the interactive console ↗